| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/28/2013 | US20130081158 Sorghum Grain Shattering Gene and Uses Thereof in Altering Seed Dispersal |
| 03/28/2013 | US20130081151 Molecular Engineering Of A Floral Inducer For Crop Improvement |
| 03/28/2013 | US20130079499 Fc binding protein and method for manufacturing same |
| 03/28/2013 | US20130079497 Pyrenyloxysulfonic acid fluorescent agents |
| 03/28/2013 | US20130079496 Collagen mixture and method of making the same |
| 03/28/2013 | US20130079495 Collagen fibrillar construction |
| 03/28/2013 | US20130079494 Processing Tissue Utilizing Supercritical Fluid |
| 03/28/2013 | US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 03/28/2013 | US20130079286 Muteins of human lipocalin 2 (lcnc,hngal) with affinity for a given target |
| 03/28/2013 | US20130079278 Novel Glucagon Analogues |
| 03/28/2013 | US20130078661 Compounds and Methods for FRET Based Measurement of Enzyme Activity |
| 03/28/2013 | US20130078281 Activators of innate immunity |
| 03/28/2013 | US20130078277 Infectious hepatitis c virus-high producing hcv variants and use thereof |
| 03/28/2013 | US20130078274 Live, oral vaccine for protection against shigella dysenteriae serotype 1 |
| 03/28/2013 | US20130078271 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 03/28/2013 | US20130078270 Her-2 peptides and vaccines |
| 03/28/2013 | US20130078269 Amyloid beta peptides, assemblies thereof, and related methods |
| 03/28/2013 | US20130078266 Immunosuppression By Blocking T Cell Co-Stimulation Signal 2 (B7/CD28 Interaction) |
| 03/28/2013 | US20130078255 Serum and tissue biomarkers of human hcc |
| 03/28/2013 | US20130078245 ANTIBODIES TO THE C3d FRAGMENT OF COMPLEMENT COMPONENT 3 |
| 03/28/2013 | US20130078220 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 03/28/2013 | DE102011109548A1 Bionic composite materials, where the materials are constructed from resilient connective tissue fibers with genetic methodology and/or organic-technological methods and from biological coupling molecules such as laminin and fibronectin |
| 03/28/2013 | DE102005048828B4 Fluoreszenzmarker und dessen Verwendung Fluorescent marker and its use |
| 03/28/2013 | CA2849822A1 Novel influenza hemagglutinin protein-based vaccines |
| 03/28/2013 | CA2849741A1 A human epithelial cell line for 3d-modelizing of cancer and treatment thereof |
| 03/28/2013 | CA2849738A1 Fibroblasts cellular model for assessing efficacy of cancer treatments by shh/ptch pathway antagonists |
| 03/28/2013 | CA2849733A1 Human keratinocytes ptch1 cell line |
| 03/28/2013 | CA2849705A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 03/28/2013 | CA2849673A1 Novel glucagon analogues |
| 03/28/2013 | CA2849587A1 Methods and compositions for characterizing phenotypes using kinome analysis |
| 03/28/2013 | CA2849434A1 Influenza virus vaccines and uses thereof |
| 03/28/2013 | CA2849301A1 Multiplex mrm assay for evaluation of cancer |
| 03/28/2013 | CA2849267A1 Regulation of sodium channels by plunc proteins |
| 03/28/2013 | CA2849244A1 Cell culture substrate comprising a laminin and a cadherin |
| 03/28/2013 | CA2848346A1 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 03/28/2013 | CA2846436A1 Serum half-life extension using immunoglobulin binding domains |
| 03/27/2013 | EP2573563A1 Screening |
| 03/27/2013 | EP2573179A1 Plants having increased yield and method for making the same |
| 03/27/2013 | EP2573175A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 03/27/2013 | EP2573170A2 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor |
| 03/27/2013 | EP2573169A1 Cartilage-specific hif-2 transgenic mouse as an animal model for arthritis, and use thereof |
| 03/27/2013 | EP2573122A2 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins |
| 03/27/2013 | EP2573113A2 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 03/27/2013 | EP2573112A1 Modulation of sirpa - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 03/27/2013 | EP2573111A1 GLP-1 compounds |
| 03/27/2013 | EP2573110A2 Peptide vaccines with Seq Id No: 174, 178, 186 or 194 for cancers expressing tumor-associated antigens |
| 03/27/2013 | EP2573109A2 Peptide vaccines comprising Seq Id 101, 80 or 100 for cancers expressing tumor-associated antigens |
| 03/27/2013 | EP2573108A1 Methods for identifying compounds capable of inhibiting degradation of PKM zeta |
| 03/27/2013 | EP2573107A1 A recombinant fusion protein |
| 03/27/2013 | EP2573105A1 P16 inka4a derived peptides for prophylaxis and therapy of HPV-associated tumors and other p16 ink4a expressing tumors |
| 03/27/2013 | EP2573104A1 Immunogenic proteins form genome-derived outer membrane of leptospira and compositions and methods based thereon |
| 03/27/2013 | EP2573103A1 Peptide domains that bind small molecules of industrial significance |
| 03/27/2013 | EP2573102A1 Peptide domains that bind small molecules of industrial significance |
| 03/27/2013 | EP2572734A2 Cytokine-based fusion proteins for treatment of immune disorders |
| 03/27/2013 | EP2572726A1 Compositions comprising pneumococcal antigens |
| 03/27/2013 | EP2572715A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572714A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572706A1 Lipid membrane structure with nuclear transferability |
| 03/27/2013 | EP2572197A1 Method and composition for the diagnosis and monitoring of inflammatory diseases |
| 03/27/2013 | EP2572190A1 Hydrophobic interaction chromatography method |
| 03/27/2013 | EP2571990A2 Universal dengue virus sequences and methods of use |
| 03/27/2013 | EP2571985A1 Method for isolating small rna-molecules using hc-pro protein |
| 03/27/2013 | EP2571900A1 Improved anti-serum albumin binding variants |
| 03/27/2013 | EP2571898A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins |
| 03/27/2013 | EP2571897A1 Novel glucagon like peptide analogs, composition, and method of use |
| 03/27/2013 | EP2571896A2 Pegylated c-peptide |
| 03/27/2013 | EP2571895A1 Methods of crystallising perforin |
| 03/27/2013 | EP2571894A1 Compositions and methods for the delivery of therapeutic peptides |
| 03/27/2013 | EP2571531A2 Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | EP2571523A2 Latent human immunodeficiency virus reactivation |
| 03/27/2013 | EP2571521A1 Parapoxvirus vectors containing rabies virus antigen |
| 03/27/2013 | EP2571519A1 Marker vaccine for classical swine fever |
| 03/27/2013 | EP2571514A1 Biglycan mutants and related therapeutics and methods of use |
| 03/27/2013 | EP2571509A1 Degradable clostridial toxins |
| 03/27/2013 | EP2284195A9 Fusion proteins useful for detecting analytes |
| 03/27/2013 | CN1913920B Influenza immunogen and vaccine |
| 03/27/2013 | CN1259141B PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 03/27/2013 | CN103003694A Method for detection of infection with human cytomegalovirus |
| 03/27/2013 | CN103003441A Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents |
| 03/27/2013 | CN103003425A Gemini virus replication inhibitor |
| 03/27/2013 | CN103003424A Antibody capable of binding to transforming growth factor alpha and having antiproliferative activity on cancer having Ras gene mutation |
| 03/27/2013 | CN103003422A New stabilizing agent for pharmaceutical proteins |
| 03/27/2013 | CN103003421A Carbohydrate binding modules with reduced binding to lignin |
| 03/27/2013 | CN103003416A Generation of induced pluripotent stem cells from small volumes of peripheral blood |
| 03/27/2013 | CN103003303A Improved anti-serum albumin binding variants |
| 03/27/2013 | CN103003301A 血清白蛋白结合分子 Serum albumin binding molecules |
| 03/27/2013 | CN103003300A Peptide conjugates of GLP-1 receptor agonists and gastrin and their use |
| 03/27/2013 | CN103003299A Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease |
| 03/27/2013 | CN103003298A C4 dicarboxylic acid production in filamentous fungi |
| 03/27/2013 | CN103003297A Asparaginase from basidiomycetes |
| 03/27/2013 | CN103003296A Polypeptides |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002910A Vaccine composition |
| 03/27/2013 | CN103002909A Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof |
| 03/27/2013 | CN103002904A Anti-angiogenic agent and method of using such agent |
| 03/27/2013 | CN103002744A DIG-11 insecticidal CRY toxins |
| 03/27/2013 | CN102994549A Method of increasing the function of an aav vector |
| 03/27/2013 | CN102994521A Woodchuck hepatitis virus-surface (WHV-S) protein gene and construction method of zero background deoxyribonucleic acid (DNA) cloning vector on basis of gene |
| 03/27/2013 | CN102994520A Infectious bursal disease VP2 gene and application thereof |
| 03/27/2013 | CN102994518A Method for preparing porcine circovirus 2 open reading frame 2 (ORF2) protein |